OBJECTIVES: We aimed to investigate whether left ventricular (LV) stunning could be detected late after coronary occlusion when coronary flow has normalized. BACKGROUND: Stunning and cumulative LV dysfunction after ischemia reperfusion has been clearly demonstrated in animal models but has been refuted in several angioplasty models in humans. However, these studies have assessed LV function early, during the reactive hyperemic phase, which might have augmented LV function. METHODS: We recruited 20 male subjects with single-vessel, type A coronary disease, and normal ventricular function. We simultaneously measured LV function with a conductance catheter and coronary flow velocity with a Combowire (Volcano Therapeutics, Inc., Rancho Cordova, California) at baseline (BL), for 30 s after a low-pressure coronary balloon occlusion for 1 min and again after 30 min, before a second balloon occlusion. RESULTS: Stunning was detected at 30 min after a 1-min balloon occlusion: stroke volume (ml) BL1: 88.4 (22.8) versus BL2: 79.4 (24.0), p = 0.04; tau (ms) BL1: 49.8 (9.0) versus BL2: 52.5 (8.9), p = 0.02, despite full recovery of coronary average peak velocity (p = 0.62). A second balloon occlusion caused cumulative LV dysfunction: stroke volume (ml) BO1: 77.3 (34.6) versus BO2 64.9 (22.9), p = 0.01. Reactive hyperemia significantly augmented early recovery systolic function: dP/dt max 30 s: +5.8% versus 30 min - 5.4%, p = 0.0009. CONCLUSIONS: Coronary occlusion for 1-min results in late stunning and cumulative LV dysfunction after 30 min. Reactive hyperemia augments stunned LV systolic function in early recovery. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
OBJECTIVES: We aimed to investigate whether left ventricular (LV) stunning could be detected late after coronary occlusion when coronary flow has normalized. BACKGROUND: Stunning and cumulative LV dysfunction after ischemia reperfusion has been clearly demonstrated in animal models but has been refuted in several angioplasty models in humans. However, these studies have assessed LV function early, during the reactive hyperemic phase, which might have augmented LV function. METHODS: We recruited 20 male subjects with single-vessel, type A coronary disease, and normal ventricular function. We simultaneously measured LV function with a conductance catheter and coronary flow velocity with a Combowire (Volcano Therapeutics, Inc., Rancho Cordova, California) at baseline (BL), for 30 s after a low-pressure coronary balloon occlusion for 1 min and again after 30 min, before a second balloon occlusion. RESULTS: Stunning was detected at 30 min after a 1-min balloon occlusion: stroke volume (ml) BL1: 88.4 (22.8) versus BL2: 79.4 (24.0), p = 0.04; tau (ms) BL1: 49.8 (9.0) versus BL2: 52.5 (8.9), p = 0.02, despite full recovery of coronary average peak velocity (p = 0.62). A second balloon occlusion caused cumulative LV dysfunction: stroke volume (ml) BO1: 77.3 (34.6) versus BO2 64.9 (22.9), p = 0.01. Reactive hyperemia significantly augmented early recovery systolic function: dP/dt max 30 s: +5.8% versus 30 min - 5.4%, p = 0.0009. CONCLUSIONS:Coronary occlusion for 1-min results in late stunning and cumulative LV dysfunction after 30 min. Reactive hyperemia augments stunned LV systolic function in early recovery. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Authors: Colm McCabe; Paul A White; Stephen P Hoole; Richard G Axell; Andrew N Priest; Deepa Gopalan; Dolores Taboada; Robert MacKenzie Ross; Nicholas W Morrell; Leonard M Shapiro; Joanna Pepke-Zaba Journal: J Appl Physiol (1985) Date: 2013-12-19
Authors: Richard G Axell; Joel P Giblett; Paul A White; Andrew Klein; James Hampton-Til; Michael O'Sullivan; Denise Braganza; William R Davies; Nick E J West; Cameron G Densem; Stephen P Hoole Journal: J Am Heart Assoc Date: 2017-06-06 Impact factor: 5.501
Authors: Sophie J Clarke; Joel P Giblett; Lucy L Yang; Annette Hubsch; Tian Zhao; Muhammad Aetesam-Ur-Rahman; Nick E J West; Michael O'Sullivan; Nichola Figg; Martin Bennett; Nicolai J Wewer Albrechtsen; Carolyn F Deacon; Joseph Cheriyan; Stephen P Hoole Journal: J Am Heart Assoc Date: 2018-11-20 Impact factor: 5.501
Authors: Joel P Giblett; Richard G Axell; Paul A White; Muhammad Aetesam-Ur-Rahman; Sophie J Clarke; Nicola Figg; Martin R Bennett; Nick E J West; Stephen P Hoole Journal: JACC Basic Transl Sci Date: 2019-04-29
Authors: Marcelo B Bastos; Daniel Burkhoff; Jiri Maly; Joost Daemen; Corstiaan A den Uil; Koen Ameloot; Mattie Lenzen; Felix Mahfoud; Felix Zijlstra; Jan J Schreuder; Nicolas M Van Mieghem Journal: Eur Heart J Date: 2020-03-21 Impact factor: 29.983
Authors: Muhammad Aetesam-Ur-Rahman; Joel P Giblett; Bharat Khialani; Stephen Kyranis; Sophie J Clarke; Tian X Zhao; Denise M Braganza; Sarah C Clarke; Nick E J West; Martin R Bennett; Stephen P Hoole Journal: BMC Cardiovasc Disord Date: 2021-05-01 Impact factor: 2.174
Authors: Muhammad Aetesam-Ur-Rahman; Tian X Zhao; Kitty Paques; Joana Oliveira; Bharat Khialani; Stephen Kyranis; Denise M Braganza; Sarah C Clarke; Martin R Bennett; Nick E J West; Stephen P Hoole Journal: J Am Heart Assoc Date: 2022-04-26 Impact factor: 6.106